Survival prediction for bladder cancer using multimodal data with quantum neural networks and transformer architectures
Abstract
To address the challenges of cross-modal information fusion in high-dimensional multimodal medical data for cancer prognosis, this study presents a hybrid diagnostic accuracy model for cancer survival prediction, integrating quantum computing with classical deep learning in a retrospective analysis of bladder cancer patients. We propose QTMPN (Quantum-Transformer Multimodal Prognostic Network), a novel framework integrating quantum neural networks (QNNs), Transformers, and graph neural networks (GNNs). For high-dimensional whole-slide pathological images (WSIs), a quantum feature extractor (QFE) is designed using parallel quantum encoding and a hybrid quantum network to capture long-range dependencies. Multimodal data-including clinical and image features-are fused via a Transformer-GNN Collaborative Fusion (TCF) module employing attention-guided dynamic graphs. Evaluated on the TCGA-BLCA dataset, QTMPN attained a survival prediction accuracy of 76.1%, outperforming baseline models such as PARADIGM and CMTA (up to 70.0%). This improvement suggests the model's enhanced capability to capture cross-modal prognostic features. Further ablation experiment validated the effectiveness of the hybrid QNNs feature extract part (QFE) in QTMPN. QTMPN presents a promising quantum-classical framework for survival risk prediction in bladder cancer, effectively modeling complex multimodal interactions. The approach contributes to improving prognostic accuracy in oncology and supporting…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Quantum dots: synthesis, bioapplications, and toxicity
- A Guide to In Silico Drug Design
- In silico toxicology protocols
- Automated in Silico Design of Homogeneous Catalysts
- In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications
- mRNA codon optimization with quantum computers
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.